Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00822172 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Cilostazol in Combination With L-Carnitine
A Phase 4 study, sponsored by Colorado Prevention Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 164
- Enrollment target
NCT00822172 is a Phase 4 study that has completed, run by Colorado Prevention Center. The registered enrollment target is 164 participants.
The verdict
NCT00822172, a Phase 4 study, has completed, sponsored by Colorado Prevention Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 164 participants
- Enrollment target
Study Summary
The purpose of this study is to see how safe and effective L carnitine taken with cilostazol is compared to placebo taken with cilostazol for people with intermittent claudication. A second purpose of the study is to see if L-carnitine is absorbed into the blood stream.
Interventions
- DRUG cilostazol
- DIETARY_SUPPLEMENT Levocarnitine tartrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2008-09 |
| Est. Completion | 2010-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00822172
The ClinicalTrials.gov registry entry for NCT00822172 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado Prevention Center, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which cilostazol is the first listed.
NCT00822172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00822172 about?
NCT00822172 is a clinical study titled "Evaluation of Cilostazol in Combination With L-Carnitine". The purpose of this study is to see how safe and effective L carnitine taken with cilostazol is compared to placebo taken with cilostazol for people with intermittent claudication. A second purpose of the study is to see if L-carnitine is absorbed into the blood stream.
What is the current status of trial NCT00822172?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 164 participants. The study started on 2008-09. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00822172?
The interventions under investigation include: cilostazol (DRUG), Levocarnitine tartrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00822172?
This trial is sponsored by Colorado Prevention Center, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.